Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, CSL commits to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Forbes and Statista create the annual list by asking employees if they would recommend their employer to friends and family.
Making and keeping friends gets more difficult when you’re an adult. But research suggests friendship is well worth the effor…
For Bleeding Disorders Awareness Month, we asked patients: “What’s the best advice anyone has given you?” We also asked them …
Adolescent and young adult rare disease patients often struggle with the switch to the adult health care system. Experts at t…
On March 6, McKenzie starts leading CSL, whose life-saving medicines are used in more than 100 countries. He begins his new r…
EURORDIS celebrates the patients, policy makers, scientists and others who dedicate their lives to the rare disease cause.
The first cohort of a new CSL internship program in Australia recently completed a three-month stint with the biotech company…
In Marburg, Germany, CSL Behring employees wanted to light up a local landmark to celebrate Rare Disease Day. But to be respo…
On the latest episode of The New Horizon Talks, experts discuss advancing patient access to specialized care and the European…
Americas
Asia Pacific
Middle East
Europe
